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Abstract
Avian influenza virus (AIV) infection is a continuing threat to both humans and poultry. Influenza virus specific CD8+ T cells
are associated with protection against homologous and heterologous influenza strains. In contrast to what has been
described for humans and mice, knowledge on epitope-specific CD8+ T cells in chickens is limited. Therefore, we set out to
identify AIV-specific CD8+ T-cell epitopes. Epitope predictions based on anchor residues resulted in 33 candidate epitopes.
MHC I inbred chickens were infected with a low pathogenic AIV strain and sacrificed at 5, 7, 10 and 14 days post infection
(dpi). Lymphocytes isolated from lung, spleen and blood were stimulated ex vivo with AIV-specific pooled or individual
peptides and the production of IFNc was determined by ELIspot. This resulted in the identification of 12 MHC B12-restricted,
3 B4-restricted and 1 B19-restricted AIV- specific CD8+ T-cell epitopes. In conclusion, we have identified novel AIV-derived
CD8+ T-cell epitopes for several inbred chicken strains. This knowledge can be used to study the role of CD8+ T cells against
AIV infection in a natural host for influenza, and may be important for vaccine development.
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Introduction
Influenza A virus infections affect both humans and poultry.
Seasonal influenza infections affect millions of humans worldwide
each year and outbreaks of avian influenza viruses (AIV) including
the highly pathogenic H5N1 viruses in wild birds and poultry
occur regularly [1,2]. Furthermore, AIV are able to infect humans
[3–5] which makes these zoo ¨notic viruses a significant threat for
human health because of their pandemic potential.
It is well established that the humoral immune response plays an
important role in controlling influenza virus infections [6–9], and
the induction of neutralizing antibodies is nowadays one of main
criteria to determine vaccine efficacy [10]. Antibodies are mainly
directed against the highly variable surface proteins haemagglu-
tinin (HA) and neuraminidase (NA) which continuously change
under ‘‘antigenic drift’’, and viruses escape from recognition by
virus-specific antibodies. Under these circumstances the induction
of cross-protective cytotoxic CD8+ T cells that recognize
conserved epitopes may be important [11].
Studies in humans and mice have shown that influenza-specific
CD8+ T cells are involved in protection against influenza virus
infection [12–14]. CD8+ T-cell responses are mainly directed
against conserved proteins like the nucleoprotein (NP) and matrix
1 (M1) protein [15,16] and have been shown to provide cross-
protection against heterologous influenza strains [17–19].
Also in chickens, which are a natural host for AIV, CD8+ T
cells are associated with protection; immunization with low
pathogenic AIV (LPAIV) of the H9N2 type results in protection
against a highly pathogenic H5N1 AIV (HPAIV) [20,21]. Cross-
reactivity between CD8+ T cells specific for seasonal influenza and
H5N1 HPAIV has been described [22] as well as cross-reactivity
between LPAIV of the H9N2 and H7N2 type [23]. Furthermore,
conserved epitopes have been detected in influenza viruses isolated
from humans and avian species [24]. Taken together, these data
show that influenza-specific CD8+ T cells exist in chickens and are
associated with protection against homologous and heterologous
influenza strains.
In contrast to what has been described for humans and mice,
knowledge on influenza epitope-specific CD8+ T cells in chickens
is limited. Cross-reactive T-cell responses to the AIV proteins HA
and NP have been reported in chickens inoculated with plasmids
expressing viral proteins HA and NP [25] or non-replicating
adenovirus vectors expressing these proteins [26]. However, AIV-
derived epitopes recognized by these CD8+ T cells are still
unknown.
The chicken MHC, also called ‘‘B locus’’, is more compact and
differently organised than the mammalian MHC. The B-F/B-L
region within the B locus contains the classical class I and class II
b
chains, and determines allograft rejection, strong mixed lympho-
cyte reactions and the cellular control of antibody production [27–
32]. For a number of common chicken MHC haplotypes, MHC
class I restricted peptide motifs have been determined. Anchor
residues involved in binding to the MHC class I molecules of these
different haplotypes were found to be just as critical as to what has
been described for mammalian MHC class I [32–34].
In this study, we set out to identify novel AIV-specific CD8+ T-
cell epitopes. To this end, epitopes in the viral proteins NP and M1
were predicted based on anchor residues described for MHC B4,
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identification of 16 novel AIV-specific CD8+ T-cell epitopes; 12
B12-restricted epitopes, 3 B4-restricted epitopes and 1 B19-
restricted epitope.
Results
Analysis of T-cell frequencies upon LPAIV infection
To investigate if infection with LPAIV would result in an influx
of T cells into the lung, we determined the frequencies of different
T-cell subsets by flowcytometry. No differences in the percentage
of CD8aa+ T cells in the lungs was observed in infected birds
compared to uninfected controls (Fig. 1A) while the number of
CD8aa+ T cells in lung did increase upon infection (Fig. 1G),
Interestingly, at 10 dpi frequencies of CD8aa+ T cells were
slightly higher in infected birds compared to uninfected controls in
both spleen (14.460.8% versus 22.563.0%, Fig. 1B) and PBMC
(33.161.5% versus 43.162.7%; Fig. 1C). This increase in splenic
CD8aa+ T cells was more pronounced when the number of cells
was analysed (50.067.1610
6 versus 143.6613.7610
6, Fig. 1H).
Figure 1. CD8+ T-cell frequencies in tissues of LPAIV infected chickens. Percentages of CD8aa+CD3+ T cells (A–C) and CD8ba+CD3+ T cells
(D–F) were analysed by flowcytometry in lung, spleen and PBMC at several days post infection. Absolute numbers were calculated by multiplying the
percentage of CD8aa+CD3+ T or CD8ba+CD3+ T cells with the total number of cells isolated from lung (G, I) and spleen (H, J). Mean plus SEM is
shown. In white: uninfected controls (UNINF, n=12), in grey infected birds (n=3 per time point).
doi:10.1371/journal.pone.0031953.g001
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compared to uninfected controls in lung (47.663.9% versus
33.761.0%; Fig. 1D), spleen (51.962.9% versus 57.663.6%;
Fig. 1E) and PBMC (30.360.5 versus 24.060.8%; Fig. 1F). Again,
differences in numbers of CD8ab+ T cells between infected birds
and uninfected controls were much higher in both lung
(18.364.1610
6 versus 64.3617.8610
6; Fig. 1I) and spleen
(191.1617.8610
6 versus 333.9640.2610
6; Fig. 1J). Similar results
were observed for numbers of CD4+ T cells and cd+ T cells (data
not shown). Thus, infection with LPAIV results in increased
numbers of CD8+ T-cells.
Identification of AIV-specific CD8+ T-cell epitopes using
peptide pools
Avian influenza virus-specific IFNc-producing CD8+ T cells
were analysed in the lung, which is a target organ of low
pathogenic avian influenza viruses. ELIspot was performed upon
stimulation of lung cells with pools of peptides that were derived
from the avian influenza viral proteins NP and M1 and were
selected based on the presence of MHC binding motifs (Tables 1
and 2, Tables S1 and S2).
Since most of the predicted MHC binders were B12-restricted,
a kinetic study was performed in which IFNc-producing AIV-
specific CD8+ T cells were analysed at 5, 7, 10 and 14 dpi in
H7N1 infected B12 chickens. For a representative image of
positive and negative ELIspot wells, see Figure S1A. At 5 dpi, a
number of peptide pools triggered IFNc production that was
higher than in the unstimulated control. Based on the strict criteria
we used in order to focus only on epitopes that elicit responses in a
majority of individuals only pool 11 induced a significantly positive
Table 1. Epitope prediction for MHC B12 based on anchor
residues.
B12: X-X-X-X-V/I-X-X-(X)-V/L/I
peptide sequence MHC restriction Viral protein
A1 NATEIRASV B12 nucleoprotein
A2 IRASVERMV B12 nucleoprotein
A3 EGRLIQNSI B12 nucleoprotein
A4 NSITIERMV B12 nucleoprotein
A5 DGKWVRELI B12 nucleoprotein
A6 AVKGVGTMV B12 nucleoprotein
A7 VGTMVMELI B12 nucleoprotein
A8 LIRMIKRGV B12 nucleoprotein
A9 GNAEIEDLI B12 nucleoprotein
A10 QNSQVFSLI B12 nucleoprotein
A11 EDLRVSSFI B12 nucleoprotein
A12 PTFSVQRNL B12 nucleoprotein
B1 VERMVGGI B12 nucleoprotein
B2 DGKWVREL B12 nucleoprotein
B3 DKEEIRRI B12 nucleoprotein
B4 AGAAVKGV B12 nucleoprotein
B5 VGTMVMEL B12 nucleoprotein
B6 VMELIRMI B12 nucleoprotein
B7 GNAEIEDL B12 nucleoprotein
B8 LPACVYGL B12 nucleoprotein
B9 QNSQVFSL B12 nucleoprotein
B10 QGRGVFEL B12 nucleoprotein
F1 VETYVLSI B12 matrix protein 1
F2 ILGFVFTL B12 matrix protein 1
F3 KDDLIENL B12 matrix protein 1
F4 LLTEVETYV B12 matrix protein 1
F5 VETYVLSIV B12 matrix protein 1
F6 LKAEIAQRL B12 matrix protein 1
F7 KTRPILSPL B12 matrix protein 1
F8 LTKGILGFV B12 matrix protein 1
F9 RRRFVQNAL B12 matrix protein 1
F10 RMGTVTTEV B12 matrix protein 1
F11 VTTEVAFGL B12 matrix protein 1
Predicted epitopes and their localization based on anchor residues that have
been described for B12 [32,33]. X represents any amino acid. Anchor residues
specific for the different MHC types are indicated in bold. A variable number of
amino acids between the anchor residues is indicted with (X).
doi:10.1371/journal.pone.0031953.t001
Table 2. Epitope prediction for MHC B4, B15, B19 and B21
based on anchor residues.
B4: X-D/E-X-X-D/E-X-X-(X)-E/L/I
A1 YEQMETGE B4 nucleoprotein
A2 YDKEEIRRI B4 nucleoprotein
A3 AEIEDLIFL B4 nucleoprotein
A4 METMDSSTL B4 nucleoprotein
B15: X-R-X-X-X-X-X-(X)-Y
A5 GRRTRIAY B15 nucleoprotein
B19: X-R-X-X-X-X-X-Y/P/L/F
A6 ERMVLSAF B19 nucleoprotein
A7 KRGVNDRNF B19 nucleoprotein
A8 GRRTRIAY B19 nucleoprotein
A9 IRGTRVVP B19 nucleoprotein
A10 TRVVPRGQL B19 nucleoprotein
A11 ERATIMAAF B19 nucleoprotein
A12 IRMMESARP B19 nucleoprotein
B1 ARPEDVSF B19 nucleoprotein
B2 TRPILSPL B19 matrixprotein 1
B3 ERGLQRRRF B19 matrixprotein 1
B4 RRRFVQNAL B19 matrixprotein 1
B5 RRFVQNAL B19 matrixprotein 1
B6 IRHENRMVL B19 matrixprotein 1
B7 MRTIGTHP B19 matrixprotein 1
B21: X-H/K/R-X-X-X-X-X-(X)-E/D-X-A/V/L/I/F/M
B8 RRDGKWVRELI B21 nucleoprotein
B9 CHSAAFEDLRV B21 nucleoprotein
B10 GRTSDMRTEII B21 nucleoprotein
B11 WRQANNGEDA B21 nucleoprotein
B12 NRMGTVTTEVA B21 matrixprotein 1
C1 LKDDLIENLQA B21 matrixprotein 1
Predicted epitopes and their localization based on anchor residues that have
been described for B4, B15, B19 and B21 [32–34]. X represents any amino acid.
Anchor residues specific for the different MHC types are indicated in bold. A
variable number of amino acids between the anchor residues is indicted with
(X).
doi:10.1371/journal.pone.0031953.t002
CD8+ T Cells and Avian Influenza Virus Infections
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31953response which was defined as the mean of the triplicates is higher
than the mean of the triplicates plus 2 times the standard error of
unstimulated control and positive in more than 2 birds (Fig. 2A–
C). As is shown in Figure 2D–F, at 7 dpi the number of pools
inducing significant IFNc production had strongly increased
which resulted in 7 significantly positive pools. Also the number
Figure 2. Identification of MHC B12-restricted CD8+ T-cell epitopes using peptide pools. Lung cells were stimulated with B12-restricted
peptide pools and IFNc-producing cells were determined by IFNc ELIspot analysis. Results for three individuals birds are shown at 5 dpi (A–C), 7 dpi
(D–F), 10 dpi (G–I) and 14 dpi (J–L). Mean plus SEM is shown, n=3 per group. Positive responses (*) and ‘‘significant’’ peptides inducing a positive
response in 2 out of 3 chickens (Q) are indicated.
doi:10.1371/journal.pone.0031953.g002
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tested significantly positive (Fig. 2G–I). Most pools were
significantly positive both at 7 dpi and 10 dp, with the exception
of pool 12 (only significantly positive at 7 dpi) and pool 5 (only
significantly positive at 10 dpi). At 14 dpi, both the number of
pools that induced IFNc-producing cells as well as the number of
significantly positive pools had decreased compared to 7 and
10 dpi (Fig. 2J–L). Three of the B12-restricted peptide pools that
were significantly positive in the lung were also found positive in
PBMC and spleen (pool 1, 3, 7; data not shown).
Testing of MHC-B4 restricted peptides in the lung of H7N1
infected B4 chickens at 10 dpi resulted in 1 significantly positive
peptide pool (Fig. 3A). No response was observed in lung cells of
infected B15 chickens upon stimulation with a peptide predicted to
bind MHC B15 (Fig. 3B). The pool of potential B21 binders
induced IFNc-producing cells in 1 out of 3 infected B21 chickens
(Fig. 3C). Testing of MHC-B19 restricted peptides resulted in 2
significantly positive peptide pools in lung (Fig. 3D–F) which was
elicited by 1 peptide (B7, Table 2). One of these B19-restricted
pools was also significantly positive in PBMC, the other B19- and
the B4-pool did not induce a significantly positive response in
spleen or PBMC (data not shown).
None of the B12 restricted pools 3, 4 and 12 induced a positive
IFNc response in MHC B4, B15, B19 or B21 birds (data not
shown). Thus, screening of NP- and M1-derived peptide pools
resulted in several candidate CD8+ T-cell epitopes that are
restricted by different MHC types.
Identification of AIV-specific CD8+ T-cell epitopes using
individual peptides
The initial screening of pools of predicted B12-restricted
peptides resulted in 14 candidate epitopes. These peptides were
tested individually together with a peptide from a pool that was not
significantly positive in the first screening as a negative control. At
7 dpi, all 14 peptides induced IFNc-producing cells in the lung,
and 8 peptides were significantly positive (Fig. 4A). Also in PBMC
many peptides tested significantly positive (Fig. S1C). Six peptides
were both significantly positive in lung and PBMC (A1, A5, A6,
A7, A11, F7, Table 1), 1 peptide was significantly positive in lung
only (B6, Table 1) and 4 peptides were significantly positive only in
PBMC (A12, B5, F2, F3, Table 1). However, these peptides
induced IFNc production in lung cells as well, but this was not
significant. At 10 dpi, the numbers of spots were lower compared
to 7 dpi both in the lung (Fig. 4B) and PBMC (Fig. S1D). Also the
number of significantly positive peptides had decreased: 1 peptide
was still positive in the lung while 5 peptides tested positive in
PBMC. Again, the peptide that was recognized by CD8+ T cells in
the lung was recognized also by CD8+ T cells in PBMC and the
peptides found positive in PBMC did induce IFNc-producing cells
in the lung also but, based on our criteria, failed to test significantly
positive. Individual testing of the B4-restricted candidate epitopes
on frozen lung cells resulted in 3 significantly positive peptides
(Fig. 5).
None of the peptides induced a positive response in cells isolated
from uninfected chickens. This was shown both in lung cells (Fig.
S2A) and PBMC (Fig. S2B). Interestingly, IFNc production by
unstimulated cells was much lower in cells from uninfected
chickens compared to cells isolated from AIV infected chickens.
IFNc production in unstimulated lung cells varied between 461
spots/200,000 cells in uninfected chickens versus 1862 spots/
200,000 cells in AIV infected chickens (Fig. S3A). Similar results
were observed in PBMC (Fig. S3B).
Thus screening of AIV-specific CD8+ T-cell epitopes using lung
cells of AIV-infected chickens resulted in 12 B12-restricted
Figure 3. Identification of MHC B4-, B15-, B19- and B21-restricted CD8+ T-cell epitopes using peptide pools. Lung cells isolated at
10 dpi were stimulated with B4 restricted peptide pools (A) or, B15 (B), B21 (C) and B19-restricted peptide pools (D–F) and IFNc producing cells were
determined by IFNc Elispot analysis. Mean plus SEM is shown, n=3 per group. Positive responses (*) and ‘‘significant’’ peptides inducing a positive
response in 2 out of 3 chickens (Q) are indicated.
doi:10.1371/journal.pone.0031953.g003
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The novel AIV-specific CD8+ T-cell epitopes are distributed
throughout the NP protein (Fig. 6A) and M1 protein (Fig. 6B)
except for 4 B12 restricted epitopes (A6, A7, B5 and B12) which
are overlapping. Different peptides from these regions are
processed and presented by B12 molecules, suggesting that this
region within the NP protein may be very immunogenic.
Discussion
In the current study we set out to identify novel CD8+ T-cell
epitopes in the NP and M1 protein of AIV. Based on epitope
prediction, 33 epitopes restricted by 5 different MHC types were
tested ex vivo using cells from MHC inbred chickens infected with a
LPAIV H7N1. This resulted in the identification of 16 novel AIV-
specific CD8+ T-cell epitopes; 12 B12-restricted epitopes, 3 B4-
restricted epitopes and 1 B19-restricted epitope.
Most of the peptides induced IFNc-producing cells at one or
more time points post infection. Strict criteria were applied to
select for positive peptides. A peptide was positive when it induced
an IFNc response that was higher than in unstimulated controls
plus 2 times the standard error and positive in at least 2 out of 3
chickens. In this way only peptides that induced a response in the
majority of chickens were selected, which is a prerequisite for the
development of a cross-protective CD8+ T-cell vaccine in
chickens. Screening of B12-resticted peptides resulted in 12 novel
epitopes of which 7 were detected both in the lung and in PBMC.
None of the peptides induced a response in uninfected chickens.
Epitopes are randomly distributed within the NP and M1 protein
except for an immunogenic region in NP that contains 4
overlapping epitopes. This region is similar to the human in-
fluenza virus-specific HLA-A2-restricted CD8+ T-cell epitope
TMVMELVRMIK [35], except for position 7 where the valine
(V) is replaced by an isoleucin (I). Within the M1 protein, the B12-
restricted epitope F7 is homologous to the HLA-A2-restricted
epitopes GILGFVFTL (M156–66) and ILGFVFTLTV (M159–68)
[35,36]. This suggests cross-reactivity between human and avian
influenza viruses similar to what has been reported before [22].
Interestingly, all epitopes were rather conserved. For example,
comparison to sequences of European H5N1 isolates resulted in
87.6–100% homology. Interestingly, more spontaneous IFNc
production was observed in cells isolated from AIV-infected
chickens compared to cells isolated from uninfected chickens. This
suggests a higher activation status of immune cells due to the
presence of the influenza virus.
In contrast to the increase in numbers of CD8aa+ and CD8ab
T cells in lung and spleen no clear changes in percentages of total
CD8+ T cells were observed between infected and uninfected
birds or differences between lung and PBMC. The latter is in
contrast with a study of De Bree et al [37] who reported a higher
frequency of influenza-specific CD8+ T cells in lung compared to
PBMC. However, in the current study frequencies of total
CD3+CD8aa and CD3+CD8ab cells rather than frequencies of
antigen-specific CD8+ T cells were analysed by flowcytometry.
Perhaps the frequencies of influenza-specific CD8+ T cells [38,39]
compared to those of the total CD8 T-cell pool are rather low, and
we were not able to detect these differences. Studies with MHC
class I tetramers are warranted to investigate differences in T-cell
frequencies upon AIV infection in the chicken in more detail.
Influxes of CD8aa+ cells into the lung upon infection with
LPAIV H7N1 and LPAIV H9N2 have been reported before
Figure 5. Identification of MHC B4-restricted CD8+ T-cell
epitopes using individual peptides. Lung cells isolated at 10 dpi
were thawed and re stimulated with B4 restricted peptides and IFNc
producing cells were determined by IFNc Elispot analysis. Mean plus
SEM is shown, n=3 per group. Positive responses (*) and ‘‘significant’’
peptides inducing a positive response in 2 out of 3 chickens (Q) are
indicated.
doi:10.1371/journal.pone.0031953.g005
Figure 4. Screening of MHC B12-restricted CD8+ T-cell epitopes using individual peptides. Lung cells were isolated, in vitro re-stimulated
with B12-restricted peptide pools and IFNc-producing cells were determined by IFNc ELIspot analysis at 7 dpi (A) and 10 dpi (B). Mean plus SEM is
shown, n=4 per group. Positive responses (*) and ‘‘significant’’ peptides inducing a positive response in 2 out of 3 chickens (Q) are indicated.
doi:10.1371/journal.pone.0031953.g004
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performed. Since chicken NK cells also express CD8a [42], these
CD8aa+ cells most likely represent a population of NK cells rather
than CD8aa+ T cells.
Inhumansandmice,influenza-specificCD8+ T cellsaredirected
to a limited number of immunodominant epitopes [15,35,43]. Our
results show several novel AIV-specific CD8+ T-cell epitopes,
however dominant epitopes are lacking. This may be related to the
organization of the chicken MHC complex. Chickens have a
‘‘minimal essential MHC’’ [32]; the properties of the single
dominantly expressed class I molecules determine whether a
chicken will respond to a particular pathogen like influenza. This
is insharp contrast to the huge and complex mammalian MHC that
expresses multiple MHC class I molecules that present pathogen-
derived peptides to CD8+ T cells. The combination of a dominant
CD8+ T-cell epitope with a dominant MHC would be dangerous
for the host; loss of the epitope, for example due to viral escape
mechanisms, would result in loss of influenza-specific immunity and
eventually death. The presence of multiple subdominant epitopes
limits the risk of loss of CD8+ T-cell immunity in case of mutations
in influenza-specific CD8+ T-cell epitopes.
In mammals, immunodominance is influenced by differences in
antigen presentation and CD8+ T-cell repertoire [44], which are
both affected by immunoproteasomes [45,46]. The absence of these
inducible proteasome genes in chickens [47] might provide an
alternative explanation for the lack of immunodominant epitopes.
Due to the use of only predicted epitopes on selected proteins,
we cannot exclude that part of the AIV-specific CD8+ T-cell
response (either targeting other viral proteins or other epitopes
within NP and M1 with non canonical binding motifs) were missed
with this strategy.
In conclusion, we have identified novel AIV-specific CD8+ T-
cell epitopes in chickens. This knowledge can be used to study the
role of CD8+ T cells against AIV infection in more detail in this
natural host for the influenza virus, and will be important for
vaccine development. Since CD8+ T-cell inducing vaccines can be
targeted towards viral proteins that are conserved between a large
variety of influenza strains, such vaccines may provide better
protection against newly arising virus strains than the current
influenza vaccines.
Materials and Methods
Ethics statement
All animal experiments were performed in strict accordance to
the Dutch Animal Experimentation Act and EU directives 86/
Figure 6. Novel AIV-specific CD8+ T cell epitopes within the LPAI H7N1 virus. Epitope mapping resulted in 11 novel CD8+ T-cell epitopes in
the nucleoprotein (A) and 5 epitopes in the matrix 1 protein (B) of the LPAI H7N1 virus. In black, B12-restricted epitopes, in grey, B4-restricted
epitopes (A) or B19-restricted epitopes (B).
doi:10.1371/journal.pone.0031953.g006
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animals used for experimental and other scientific purposes. The
experimental protocols were approved by the Committee on
Animal Experiments of the University of Utrecht (DEC
2008.II.01.010) and performed in the Central laboratory Animal
Research Facility of the University of Utrecht, which has
AAALAC (Association for Assesment and Accreditation of
Laboratory Animal care) accreditation.
Animals
One-day old chickens of the following MHC inbred lines
were obtained from Dr. H.J. Madsen: line 2 (MHC B12), line 4
(MHC B4), line 22 (MHC B15), line 21-19 (B19) and line 21-21
(MHC B21) [48]. Chickens were housed in groups and fed ad
libitum on commercial feed. At 3 weeks, chickens were infected
with the low pathogenic avian influenza strain H7N1 isolate A/
chicken/Italy/1067/99 (kindly provided by Dr. W. Dundon).
Virus was diluted in sterile PBS at a concentration of 1610
8
EID50/ml and chickens were inoculated intranasally and
intratracheally (100 ml each). Uninfected controls chickens were
inoculated with PBS. At 5, 7, 10 and 14 days post infection,
birds were euthanized using cervical dislocation and lungs,
spleen and blood were collected. In the second animal
experiment, B12 birds were infected with H7N1 or PBS as
described before. Birds were euthanized at 7 and 10 dpi and
lungs and blood were collected.
Isolation of cells
In order to obtain a single cell suspension, lung tissue was cut
into small pieces and digested in RPMI containing collagenase
A from Clostridium histolyticum and DNAse I isolated from
bovine pancreas (Roche Applied Science, Almere, the Nether-
lands) for 30 min at 37uC, and homogenised using a 70 mMc e l l
strainer (Beckton Dickinson (BD), Franklin Lakes, NJ, USA).
Spleens were homogenised using a 70 mMc e l ls t r a i n e r .V i a b l e
cells were isolated from lung, spleen and blood by Ficoll-Paque
density gradient centrifugation. Cells were resuspended in
‘‘complete medium’’ which is RPMI medium supplemented
with 10% heat inactivated FCS, 100 U/ml penicillin, 100 mg/
ml streptomycin and 2 mM glutamax (Gibco BRL, United
Kingdom) and were either used directly or frozen and stored in
liquid nitrogen
Peptide pools and peptides
The database SYFPEITHI (http://www.syfpeithi.de/home.
htm) was used to predict epitopes in the AIV-proteins NP and
M1 based on anchor residues described for MHC B4, B12, B19
and B21 [32–34]. Predictions resulted in 33 B12-restricted, 14
B19-restricted, 4 B4-restricted, 1 B15-restricted and 6 B21-
restricted epitopes (Table 1, Table 2). Individual peptides of 8–
11 amino acids were synthesized (Pepscan, Lelystad, The
Netherlands), dissolved in DMSO, diluted in PBS to a
concentration of 2 mg/ml and subsequently pooled. This
resulted in 1 pool of B4-restricted peptides, 12 pools of B12-
restricted peptides, 8 pools of B19-restricted peptides, and 1
pool of B21-restricted peptides. For the B12- and B19-restricted
peptides, peptide pools were made using a matrix approach
[49] to ensure that each peptide is part of two pools. B4- and
B21-restricted peptides were pooled in one pool each (Tables S1
a n dS 2 ) .P e p t i d ep o o l sw e r ea l i q u o t e da n ds t o r e da t220uC
until use.
Flowcytometry
Frequencies of CD8aa+CD3+,C D 8 ab+CD3+,a n dC D 4 +
CD3+ were analysed by flowcytometry. Cells were stained with
mouse-anti-chicken CD3-PE (clone CT-1; IgG1) together with
mouse-anti-chicken CD8a- FITC (clone CT-8; IgG1) and a
biotin labelled mouse-anti-chicken CD8b (clone EP42, IgG2a).
Alternatively, cells were stained with mouse-anti-chicken CD3-
PE together with mouse-anti-chicken CD4-biotin (clone CT-4,
IgG1) and mouse-anti-chicken TCRcd ( T C R - 1 ,I g G 1 ) .A l l
antibodies were obtained from Southern Biotech (SBA), San
Diego, CA, USA. Stainings were performed for 20 min at 4uC.
Next, cells were washed using PBS supplemented with 0.5%
(v/v) bovine serum albumin (PBA) and stained with strepta-
vidin-APC (BD Biosciences, Franklin Lakes, NJ, USA) for
20 min at 4uC. Cells were washed in PBA and fixed using a 2%
final concentration of paraformaldehyde (Merck, Darmstadt,
Germany) for 10 minutes at room temperature. Afterwards,
cells were washed once in PBA and flowcytometry was
performed. At least 50,000 events were acquired using a
FACS Calibur flowcytometer (BD). All data were analyzed
using the software program FlowJO (Threestar Inc, Ashland,
OR, USA).
IFNc ELIspot analysis
IFNc ELIspot was performed as previously described [50].
Briefly, 96 well MulitiscreenH HTS, (Millipore, Billerica, MA,
USA) were incubated with 70% ethanol for 1 min at room
temperature and washed 1 time with H2O followed by 1 wash
with PBS. Wells were coated with mouse-anti-chicken-IFNc
(2.5 mg/well in PBS; chicken IFNc CytoSet
TM (Invitrogen,
Carlsbad, CA, USA) and incubated overnight at 4uC. Next,
plates were washed 2 times with complete medium and blocked
with complete medium at 41uC, 5% CO2.A f t e r1 h o u r ,
complete medium was discarded and cells were seeded at
2610
5 cells/well in 200 ml in triplicate. Cells were stimulated
with either peptides pools (final concentration of the individual
peptides is 1 mg/ml) or individual peptides (1 mg/ml) for
24 hours at 41uC, 5% CO2. As a positive control for the
capacity of cells to produce IFNc a combination of 50 ng/ml
phorbol myristrate acetate (PMA) and 500 ng/ml Ionomycin
was used (Sigma-Aldrich, Zwijndrecht, the Netherlands). Un-
stimulated cells were used as negative control. Next, plates were
washed 5 times with PBS supplemented with 0.05% Tween-20
(PBS-Tween) and incubated with anti-chicken IFNc biotin
(1 mg/well in PBS, Chicken IFNc CytoSet
TM, Invitrogen) for
1 hour at room temperature. Plates were washed 5 times with
PBS-Tween and incubated with poly-HRP (0.2 mg/well; San-
quin, Amsterdam, the Netherlands) for 1 hour at room
temperature. Plates were washed again 5 times with PBS-Tween
and TMB was added (50 ml/well, TMB for ELIspot, Sanquin).
After spots became visible, plates were washed with tap water
and airdried. Plates were analysed using the AELVIS automated
spot analyzer (Sanquin). For a representative example, see Fig.
S1A). Positive responses were defined as ‘‘the mean of the
triplicates is higher than the mean of the triplicates plus 2 times
the standard error of unstimulated control’’. Peptides inducing a
response in 2 out of 3 chickens were defined as ‘‘significant’’.
Supporting Information
Figure S1 Screening of MHC B12-restricted CD8+ T-cell
epitopes using individual peptides. (A) A representative
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stimulated with medium (unstimulated), the B12 restricted peptide
pool 3 or PMA/Ionomycin. Lung cells were isolated, in vitro re-
stimulated with B12-restricted peptides and IFNc-producing cells
were determined by IFNc ELIspot analysis. A representative
example of lung cells isolated at 7 dpi is shown (B) together with
results for PBMC isolated at 7 dpi (C) and 10 dpi (D). Mean plus
SEM is shown, n=4 per group. Positive responses (*) and
‘‘significant’’ peptides inducing a positive response in 2 out of 3
chickens (Q) are indicated.
(TIF)
Figure S2 Screening of MHC B12-restricted CD8+ T-
cell epitopes using individual peptides in uninfected
birds. Cells from uninfected (PBS infected) birds were isolated,
in vitro re-stimulated with B12-restricted peptide pools and IFNc-
producing cells were determined by IFNc ELIspot analysis at
7 dpi in lung (A) and PBMC (B). Mean plus SEM is shown, n=3
per group.
(TIF)
Figure S3 Higher spontaneous IFNc production by
unstimulated cells isolated from AIV-infected chickens.
Lung cells were isolated from uninfected and AIV-infected
chickens, cultured for 24 hours in vitro in the absence of peptides
and IFNc-producing cells were determined by IFNc ELIspot
analysis at 7 dpi in lung (A) and PBMC (B). Mean plus SEM is
shown, n=3 per group. In white, responses in uninfected chickens;
in grey, responses in AIV-infected chickens.
(TIF)
Table S1 Thirty-three MHC B12 restricted individual
peptides were assigned to 12 pools using a matrix
approach.
(DOC)
Table S2 Fourteen MHC B19 restricted individual
peptides were assigned to 8 pools using a matrix
approach.
(DOC)
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